Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor whose role in energy metabolism is obscure. Most of its physiological ligands are derived from tryptophan (TRP). Here, fifty male C57BL/6JRccHsd mice were assigned to one of five feeding groups, control diet (CD), high-fat diet (HFD; 45 % of energy from fat), HFD with only 70 % of the regular TRP concentration (HFDtrp), HFD supplemented with a weakly toxic AHR agonist C2 (HFDc2), or HFDtrp with C2 (HFDtrp-c2). All diets contained 2 % cholesterol and were fed for 18 weeks. On weeks 14-16, the mice were tested for gas exchange and locomotor activity, and on weeks 15-17 for glucose tolerance (GTT) and insulin sensitivity (ITT). At termination, tissue samples were collected for biochemical and AI-assisted histological analyses. Body weight gain (BWG) was only 28-38 % higher in the HFD groups than in the CD group, but the HFD-fed mice accumulated 43-61 % more fat. Calorie intake was greater in the two low-TRP groups than in the two other HFD groups, while BWG remained similar. C2 induced expression (an index of AHR activity) in all tissues examined and increased the ratio of micro-/macrosteatosis in the liver. The HFDs tended to reduce insulin sensitivity, CO production, and the ability to respond appropriately to a low-temperature challenge. These findings suggest that the effects of AHR activity modulation on energy balance are strongly context-dependent. A sensitive response to long-term AHR activation appears to be elevated micro-/macrosteatosis ratio in the liver when exposed to HFD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12274841PMC
http://dx.doi.org/10.1016/j.toxrep.2025.102083DOI Listing

Publication Analysis

Top Keywords

high-fat diet
8
aryl hydrocarbon
8
hydrocarbon receptor
8
receptor ahr
8
ahr activation
8
insulin sensitivity
8
hfd groups
8
ahr activity
8
ahr
6
hfd
6

Similar Publications

Hyperlipidemia is a common chronic disease characterized by elevated levels of lipids in the blood. There is some evidence that suggests that berberine (BBR) might be beneficial for the treatment of hyperlipidemia. However, its low intestinal bioavailability limits its potential therapeutic action.

View Article and Find Full Text PDF

Kinases are activators of well‑known inflammatory cascades implicated in metabolic disorders, and abnormal activation of casein kinase II (CK2) is associated with several inflammatory disorders. However, thus far, its role in the low‑grade chronic inflammatory response known as 'metaflammation', which is a hallmark of obesity and type 2 diabetes, has not yet been elucidated. The present study aimed to evaluate the role of CK2 in diet‑induced metaflammation and the effects of the CK2 inhibitor 4,5,6,7‑tetrabromobenzotriazole (TBB) on a murine model fed a high‑fat‑high‑sugar (HFHS) diet.

View Article and Find Full Text PDF

Purpose: CL316,243 (CL), a beta 3 adrenergic receptor (B3-AR) agonist has 'exercise mimetic' effects in adipose tissue (AT). CL may also positively affect skeletal muscle (SM), yet the role of estrogen receptor beta (ERβ) in mediating SM-specific effects of CL is not known. We investigated the effects of CL on SM metabolism, as well as the role played by ERβ.

View Article and Find Full Text PDF

MR409, a synthetic growth hormone-releasing hormone (GHRH) analogue, has demonstrated therapeutic potential in enhancing islet cell transplantation efficacy in diabetes mice and exerts beneficial effects on cardiovascular diseases. The present study investigated the renoprotective effects of MR409 on db/db and streptozotocin (STZ)-induced diabetic mice, focusing on its role in modulating oxidative stress and ferroptosis. db/db or STZ mice combined with high fat diet were used to establish the type 2 diabetic models.

View Article and Find Full Text PDF

High-fat (HF) diets contribute to obesity, insulin resistance, fatty liver, gut microbiota dysbiosis, oxidative stress, and low-grade chronic inflammation. This study evaluated the preventive effects of dietary Type 2 resistant starch (RS2) from high-amylose maize and low-dose d-fagomine (FG) from buckwheat on these metabolic disturbances. Male Wistar-Kyoto rats (9-10 weeks old) were assigned to four diet groups for 10 weeks: standard (STD) diet, HF diet (45% kcal from fat), HF + RS diet (15% RS2), and HF + FG diet (0.

View Article and Find Full Text PDF